Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.
Listen in to PwC Next in Health podcast conversations here or follow our series Apple Podcasts, Spotify, YouTube Music and more.
PwC specialists unpack how regulatory changes, pricing pressures, and global innovation are influencing pharma and health services M&A—and what companies should do now to reassess pricing strategies, stabilize supply chains, and navigate policy risk.
PwC specialists break down MFN drug pricing and what companies should do now to reassess pricing, supply chains, and policy risks.
Explore how pharma and biotech leaders can navigate FDA disruption with smarter submissions, regulatory agility, and global risk mitigation strategies.
Explore the rise of China’s biotech industry and what it means for U.S. pharma, from innovation and partnerships to diligence and global strategy.
